Skip to main content
BALCHEM CORP logo

BALCHEM CORP — Investor Relations & Filings

Ticker · BCPC ISIN · US0576652004 LEI · 549300VR70OPMHUI3557 US Manufacturing
Open in API
Filings indexed 1,262 across all filing types
Latest filing 2011-12-06 Regulatory Filings
Country US United States of America
Listing US BCPC

About BALCHEM CORP

https://balchem.com/

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products. The company operates through three primary segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. The Human Nutrition & Health division is a leader in essential nutrients like choline, chelated minerals, and vitamin K2, utilizing advanced microencapsulation technologies for the food and nutritional supplement markets. The Animal Nutrition & Health segment provides a portfolio of products to meet the nutritional needs of animals, with a key position in choline chloride. The Specialty Products segment includes Performance Gases for various industrial applications and Plant Nutrition solutions. Balchem is focused on delivering innovative, science-based solutions to improve health and nutrition.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2011
Regulatory Filings Classification · 90% confidence The document text appears to be encoded or corrupted and does not contain any readable content, keywords, regulatory headers, or references to specific report types, fiscal periods, or regulatory bodies. The length is 10,969 characters, which is substantial, but the content is not interpretable as a financial or regulatory document. Given the lack of meaningful information and the fallback rule, the document should be classified as a Regulatory Filing (RNS), which is the default category for filings that do not fit other specific categories.
2011-12-06 English
BALCHEM CORPORATION 8-K 12-1-2011
Notice of Dividend Amount Classification · 95% confidence The document is a Form 8-K filing dated December 1, 2011, for Balchem Corporation. It primarily announces a dividend declared by the Board of Directors, as stated in the Regulation FD Disclosure section. The document includes a press release as an exhibit regarding the dividend declaration. The text does not contain detailed financial statements or comprehensive financial data but is an announcement of a dividend. According to the filing definitions, announcements of dividend amounts and payment details fall under the category 'Notice of Dividend Amount' (DIV). The document length is short (2298 characters), consistent with an announcement rather than a full report. Therefore, the appropriate classification is DIV with high confidence.
2011-12-05 English
FORM 4
Director's Dealing
2011-12-05 English
FORM 4
Director's Dealing
2011-12-02 English
FORM 4
Director's Dealing
2011-12-02 English
FORM 4
Director's Dealing
2011-12-02 English

Browse filings by year

32 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.